Wolters Kluwer N.V.
Wolters Kluwer completes capital reduction
Wolters Kluwer completes capital reduction
PRESS RELEASE
Wolters Kluwer completes capital reduction
Alphen aan den Rijn – September 19, 2025 – Wolters Kluwer, a global leader in information solutions, software and services, announces today that it has completed the reduction in share capital approved by shareholders at the Annual General Meeting of Shareholders held on May 15, 2025.
The company confirms that 6,000,000 ordinary shares held in treasury have now been cancelled. The total number of issued ordinary shares is therefore reduced to 232,516,153 (previously 238,516,153).
Following this cancellation, the number of shares held in treasury is now 2,793,930 and, in accordance with regulatory requirements, Wolters Kluwer has notified the Dutch Authority for the Financial Markets (AFM) of the change in its issued share capital and that it currently holds 1.20% of total issued ordinary shares.
Shares repurchased by the company are added to and held as treasury shares, to be used for capital reduction purposes through share cancellation. Part of these treasury shares may be retained and used to meet future obligations under share-based incentive schemes.
# # #
About Wolters
Wolters Kluwer (Euronext: WKL) is a global leader in information solutions, software, and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, The Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.
Media | Investors / Analysts |
Stefan Kloet | Meg Geldens |
Global Communications | Wolters Kluwer |
Wolters Kluwer | Investor Relations |
stefan.kloet@wolterskluwer.com | ir@wolterskluwer.com |
m +31 612 22 36 57 |
Forward-looking statements and other important legal information
This press release contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU).
Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Scandinavian Investment Group A/S19.9.2025 20:22:33 CEST | Pressemeddelelse
Resultat aktietilbagekøbsprogram 17-19 september 2025
Kensana Health Inc.19.9.2025 19:29:40 CEST | Press release
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
Digitalist Group Oyj19.9.2025 19:00:31 CEST | Press release
Digitalist Group structures its financing
Leading Edge Materials Corp.19.9.2025 18:00:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025
Sironax19.9.2025 17:00:00 CEST | Press release
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom